Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 138-143

  Cruz, Marcelo R S ^a   Prestes, Júlio C ^a   Gimenes, Daniel L ^a   Fanelli, Marcello F ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Breast neoplasms; disease free survival; drug therapy; fertility; gonadotropin releasing hormone; goserelin; prognosis; survival analysis; tamoxifen

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GONADORELIN AGONIST; GOSERELIN; LETROZOLE; LEUPRORELIN; METHOTREXATE; TAMOXIFEN; TRIPTORELIN;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVOR; CLINICAL TRIAL; CRYOPRESERVATION; DRUG EFFICACY; DRUG MEGADOSE; EARLY MENOPAUSE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MULTIPLE CYCLE TREATMENT; OBSERVATION; OVARIAN PRESERVATION; OVULATION INDUCTION; PREMENOPAUSE; PRIORITY JOURNAL; PROTECTION; SYSTEMATIC REVIEW;

ANIMALS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FERTILITY; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE;

EID: 77952553109     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.055     Document Type: Article

References (35)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Hankey B.F., Miller B., Curtis R., and Kosary C. Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 16 (1994) 7-14
3. Bines J., Oleske D.M., and Cobleigh M.A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14 (1996) 1718-1729
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
5. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thurlimann B., and Senn H.J. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18 (2007) 1133-1144
6. National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology-v.2 (2008). http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf Available at http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf. Accessed on September 16, 2008
7. Adami H.O., Malker B., Holmberg L., Persson I., and Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315 (1986) 559-563
8. Nixon A.J., Neuberg D., Hayes D.F., Gelman R., Connolly J.L., Schnitt S., et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12 (1994) 888-894
9. Anders C.K., Hsu D.S., Broadwater G., Acharva C.R., Foekens J.A., Zhang Y., et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26 (2008) 3324-3330
10. Goodwin P.J., Ennis M., Pritchard K.I., Trudeau M., and Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 17 (1999) 2365-2370
11. Cohen I., and Speroff L. Premature ovarian failure: update. Obstet Gynecol Surv 46 (1991) 156-162
12. Minton S.E., and Munster P.N. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 9 (2002) 466-472
13. Kalantaridou S.N., Davis S.R., and Nelson L.M. Premature ovarian failure. Endocrinol Metab Clin North Am 27 (1998) 989-06
14. Partridge A.H., Gelber S., Peppercorn J., Sampson E., Knudsen K., Laufer M., et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22 (2004) 4174-4183
15. Recchia F., Sica G., De Filippis S., Saggio G., Rosselli M., and Rea S. Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. Anticancer Drugs 13 (2002) 417-424
16. Recchia F., Saggio G., Amiconi G., Di Blasio A., Cesta A., Candeloro G., and Rea S. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106 (2006) 514-523
17. Partridge A.H., and Winer E.P. Fertility after breast cancer: questions abound. J Clin Oncol 23 (2005) 4259-4261
18. National Cancer Institute. Clinical Trials. Available at http://www.cancer.gov/clinicaltrials.
19. Fox K.R., Scialla J., and Moore H. Preventing chemotherapy-associated amenorrhea (CRA) with leuprolide during adjuvant chemotherapy for early-stage breast cancer. Proc Am Soc Clin Oncol 22 (2003) 13 (abstr 50)
20. Del Mastro L., Catzeddu T., Boni L., Bell C., Sertoli M.R., Bighin C., et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 17 (2006) 74-78
21. Urruticoechea A., Arnedos M., Walsh G., Dowsett M., and Smith I.E. Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). Breast Cancer Res Treat 110 (2008) 411-416
22. Oktay K., Buyuk E., Davis O., Yermakova I., Veeck L., and Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 18 (2003) 90-95
23. Oktay K., Buyuk E., Libertella N., Akar M., and Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23 (2005) 4347-4353
24. Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 23 (2005) 3858-3859
25. Wildiers H., Neven P., Amant F., D'hooghe T., and Paridaens R. Fertility preservation in (breast) cancer patients: is it safe?. J Clin Oncol 24 (2006) 5335-5336
26. Albain K.S., Green S.J., Ravdin P.M., Cobau C.D., Levine E.G., Ingle J.N., et al. Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent: initial results from intergroup trial 0100 (SWOG-8814). Proc Am Soc Clin Oncol 21 (2002) 37a (abstr 143)
27. Yarnold J.R., Bliss J.M., Earl H., George D., Lawrence D., Mortazaviet S.H., et al. Ovarian ablation in pre-menopausal women with early breast cancer prescribed 5 years tamoxifen or tamoxifen plus chemotherapy: results from the UK NCRI adjuvant breast cancer interantional trial of 2144 patients. J Clin Oncol 22 Suppl (2004) 11s (abstr 535)
28. Singh K.L., Davies M., and Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation, and the role of ovarian reserve testing. Hum Reprod Update 11 (2005) 69-89
29. Reh A., Oktem O., and Oktay K. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 90 (2008) 1635-1639
30. Anderson R.A., Themmen A.P., Al-Qahtani A., Groome N.P., and Cameron D.A. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 21 (2006) 2583-2592
31. Licciardi F.L., Liu H.C., and Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64 (1995) 991-994
32. Lee S.J., Schover L.R., Partridge A.H., Patrizio P., Wallace W.H., Hagerty K., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24 (2006) 2917-2931
33. Mor V., Allen S., and Malin M. The psychosocial impact of cancer on older versus younger patients and their families. Cancer 74 (1994) 2118-2127
34. Wenzel L.B., Fairclough D.L., Brady M.J., Cella D., Garrett K.M., Kluhsman B.C., et al. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 86 (1999) 1768-1774
35. Compas B.E., Stoll M.F., Thomsen A.H., Oppedisano G., Epping- Jordan J.E., and Krag D.N. Adjustment to breast cancer: age-related differences in coping and emotional distress. Breast Cancer Res Treat 54 (1999) 195-203